Frontera Therapeutics Inc. has developed FT-017, an adenovirus-associated vector(AAV)-based gene therapy that carries a human MYBPC3 optimized codon, for the treatment of hypertrophic cardiomyopathy ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...